|
Index of reports
> Cases resulting in death (20)
> Cases with Pneumonia (4)
Below is the selection of adverse event reports related to Noxafil (Posaconazole) that includes cases resulting in death where reactions include pneumonia.
Adverse event in female receiving Noxafil (Posaconazole)
Reported by a health professional (non-physician/pharmacist) from Germany on 2007-06-19
Patient: female, weighing 48.1 kg (105.8 pounds)
Adverse reactions / side effects: Blood Bilirubin Increased, Hypovolaemic Shock, Pruritus, Disseminated Intravascular Coagulation, Prothrombin Time Prolonged, Pyrexia, B-Cell Lymphoma Stage III, Metabolic Disorder, Lung Injury, Bronchopulmonary Aspergillosis, Pneumonia, Blood Lactate Dehydrogenase Increased, General Physical Health Deterioration, Haemolysis, Fungal Infection, Aspartate Aminotransferase Increased, Disturbance in Attention, Colon Polypectomy, Hypersensitivity, Endometriosis, Osteoporosis, Chills, Salpingo-Oophorectomy, Somnolence, Polyneuropathy, Chest X-RAY Abnormal, Stem Cell Transplant, Capillary Leak Syndrome, Fatigue, Gamma-Glutamyltransferase Increased, Thyroidectomy, Liver Function Test Abnormal, Pleural Effusion, Antithrombin III Decreased, Thrombocytopenia, Haptoglobin Decreased, Haemoptysis, Laparoscopic Sterilisation, Rash, Varicose Vein, T-Cell Lymphoma Stage III, Osteoarthritis, Renal Failure, Diarrhoea, Cardiac Failure, Sepsis, Acute Hepatic Failure, Asthenia, Venous Stent Insertion, Infection
Adverse event resulted in: death, hospitalization
Suspect drug(s):
Tegretol
Dosage: 200 mg/day
Administration route: Oral
Noxafil
Dosage: unk, unk
Start date: 2006-12-15
End date: 2006-12-20
Other drugs received by patient: Cytarabine; Cytarabine; Rituximab; Cisplatin; Dexamethasone 0.5mg TAB; Carmustine; Etoposide; Melphalan; Liskantin; Kalinor Retard; Ambisome; Ambisome; Ambisome; Ambisome; Cancidas; Cancidas; Cancidas; Diflucan; Vfend; Acyclovir; Clexane; Palifermin; Palifermin; Tavanic
Adverse event in male receiving Noxafil (Posaconazole)
Reported by a physician from Germany on 2007-05-31
Patient: male
Adverse reactions / side effects: Pneumonia, Treatment Noncompliance, Septic Shock
Adverse event resulted in: death
Suspect drug(s):
Noxafil (Posaconazole)
Adverse event in female receiving Noxafil (Posaconazole)
Reported by a physician from Germany on 2007-05-15
Patient: female, weighing 48.1 kg (105.8 pounds)
Adverse reactions / side effects: Blood Bilirubin Increased, Pruritus, Disseminated Intravascular Coagulation, Prothrombin Time Prolonged, Pyrexia, Chemotherapy, B-Cell Lymphoma Stage III, Metabolic Disorder, Bronchopulmonary Aspergillosis, Pneumonia, Blood Lactate Dehydrogenase Increased, General Physical Health Deterioration, Haemolysis, Fungal Infection, Aspartate Aminotransferase Increased, Disturbance in Attention, Colon Polypectomy, Hypersensitivity, Osteoporosis, Endometriosis, Chills, Salpingo-Oophorectomy, Somnolence, Chest X-RAY Abnormal, Polyneuropathy, Stem Cell Transplant, Fatigue, Gamma-Glutamyltransferase Increased, Thyroidectomy, Liver Function Test Abnormal, Pleural Effusion, Thrombocytopenia, Antithrombin III Decreased, Haptoglobin Decreased, Haemoptysis, Laparoscopic Sterilisation, Rash, Varicose Vein, T-Cell Lymphoma Stage III, Osteoarthritis, Diarrhoea, Sepsis, Acute Hepatic Failure, Asthenia, Venous Stent Insertion, Infection
Adverse event resulted in: death, hospitalization
Suspect drug(s):
Tegretol
Dosage: 200 mg/day
Administration route: Oral
Noxafil
Dosage: unk, unk
Start date: 2006-12-15
End date: 2006-12-20
Other drugs received by patient: Arac; Arac; Rituximab; Cisplatin; Dexamethasone 0.5mg TAB; Carmustine; Etoposide; Melphalan; Liskantin; Kalinor Retard; Ambisome; Ambisome; Ambisome; Ambisome; Cancidas; Cancidas; Cancidas; Diflucan; Vfend; Acyclovir; Clexane; Palifermin; Palifermin; Tavanic
Adverse event in 38 year old female receiving Noxafil (Posaconazole)
Reported by a physician from Belgium on 2007-03-27
Patient: 38 year old female, weighing 34.0 kg (74.8 pounds)
Adverse reactions / side effects: Pneumonia, Respiratory Failure, Respiratory Arrest, Inflammation
Adverse event resulted in: death, life threatening event, hospitalization
Suspect drug(s):
Noxafil (Posaconazole)
Other drugs received by patient: Posaconazole (Prev.)
|
